Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Should Allow Linkages Between "Help-Seeking" and Full Product Ads, Pfizer Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Similarities between disease awareness ads and full product ads, which contain risk information, could benefit consumers, Pfizer says in comments on FDA's draft DTC guidance. The company is working with consumer and medical groups to generate such evidence.
Advertisement

Related Content

Pfizer Seeks Better Definition Of FDA Limits On Ad Similarity, Proximity
Pfizer Seeks Better Definition Of FDA Limits On Ad Similarity, Proximity
Pfizer Seeks Better Definition Of FDA Limits On Ad Similarity, Proximity
FDA Extends Comment Period For Direct-To-Consumer Advertising Guidances
Disease Awareness Ads Must Be Different, Distant From Branded Ads, FDA Says
Disease Awareness Ads Must Be Different, Distant From Branded Ads, FDA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS060389

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel